Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 658

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement

Open access
Pope, Harrison G., Wood, Ruth I., Rogol, Alan, Nyberg, Fred, Bowers, Larry, Bhasin, Shalender·2014·Endocrine Reviews
DOI 10.1210/er.2013-1058
Open this paper in CoChat — free account

Abstract

Despite the high prevalence of performance-enhancing drug (PED) use, media attention has focused almost entirely on PED use by elite athletes to illicitly gain a competitive advantage in sports, and not on the health risks of PEDs.There is a widespread misperception that PED use is safe or that adverse effects are manageable.In reality, the vast majority of PED users are not athletes but rather nonathlete weightlifters, and the adverse health effects of PED use are greatly underappreciated.This scientific statement synthesizes available information on the medical consequences of PED use, identifies gaps in knowledge, and aims to focus the attention of the medical community and policymakers on PED use as an important public health problem.PED users frequently consume highly supraphysiologic doses of PEDs, combine them with other PEDs and/or other classical drugs of abuse, and display additional associated risk factors.PED use has been linked to an increased risk of death and a wide variety of cardiovascular, psychiatric, metabolic, endocrine, neurologic, infectious, hepatic, renal, and musculoskeletal disorders.Because randomized trials cannot ethically duplicate the large doses of PEDs and the many factors associated with PED use, we need observational studies to collect valid outcome data on the health risks associated with PEDs.In addition, we need studies regarding the prevalence of PED use, the mechanisms by which PEDs exert their adverse health effects, and the interactive effects of PEDs with sports injuries and other high-risk behaviors.We also need randomized trials to assess therapeutic interventions for treating the adverse effects of PEDs, such as the anabolic-androgen steroid withdrawal syndrome.Finally, we need to raise public awareness of the serious health consequences of PEDs.(Endocrine Reviews 35: 341-375, 2014) I. Introduction II.Definitions III.The Process of Data Gathering and Synthesis IV.Factors Contributing to the Limited Appreciation of the Adverse Effects of PEDs V. A History of PED Use VI.Epidemiology of PED Use A. Age of onset B. Prevalence of use C. The types and patterns of PED use D. Association of PED use with other high-risk behaviors VII.Adverse Health Effects of PEDs A. Androgenic-anabolic steroids B. Human GH C. Insulin D. Erythropoiesis-stimulating agents VIII.The Interactive Effects of Performance-enhancing Drugs and Sports Injury IX.Gene Doping X. Gaps in Our Knowledge I. Introduction T he Endocrine Society's Scientific Statement Task Force (SSTF) deemed the medical consequences of performance-enhancing drug (PED) use an important topic for a

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/er.2013-1058

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

Metadata

Authors
Pope, H. G., Wood, R. I., Rogol, A., Nyberg, F., Bowers, L., & Bhasin, S.
Venue
Endocrine Reviews
Publisher
The Endocrine Society
Published
2013-12-17
Volume
35
Issue
3
Pages
341-375
ISSN
  • 0163-769X (ISSN-L)
  • 1945-7189
DOI
10.1210/er.2013-1058
OpenAlex
W2086970328
Cited by
658
References
21
FWCI
75.22
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.